Naloxone en France : prévention des surdoses d’opioïdes grâce à des programmes innovants (notice n° 1374035)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03040cam a2200301 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250629031719.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Frauger, Elisabeth |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Naloxone en France : prévention des surdoses d’opioïdes grâce à des programmes innovants |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 19 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | In France, according to the DRAMES and DTA pharmaco-surveillance systems, the majority of drug-related deaths involve opioids. Naloxone, the antidote for opioid overdoses, has been used in medical settings since the 1970s. Since 2016, take-home naloxone (THN) has been available. Naloxone remains underutilized for several reasons, including lack of awareness about naloxone among certain professionals and users, limited access, stigma, and ignorance about overdose risks. In this context, it is important to support professionals in setting up naloxone programs to raise awareness among users and their support networks about overdose risks and the proper use of naloxone. This article first describes the different forms of THN in France and then offers guidance to addiction professionals in how to structure such programs. To illustrate this, the actions of the POP program (Prevention and risk reduction of opioid-related overdoses in the PACA region) are described in detail. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | En France, d’après les dispositifs de pharmacosurveillance DRAMES et DTA, la majorité des décès sont liés à un opioïde. La naloxone, antidote spécifique des surdoses des opioïdes, est utilisée en milieu médical depuis les années 1970. Depuis 2016, des formes de naloxone prêtes à l’emploi sont disponibles. Actuellement, l’usage de la naloxone prête à l’emploi reste sous-utilisé pour plusieurs raisons (méconnaissance de la naloxone prête à l’emploi par certains professionnels et usagers, contraintes réglementaires, stigmatisation, méconnaissance des risques…). Dans ce contexte, il est important d’accompagner les professionnels à mettre en place des programmes naloxone pour sensibiliser les usagers et de leur entourage au risque de surdose lié aux opioïdes et au bon usage de la naloxone. Cet article décrit tout d’abord les différentes formes de naloxone prête à l’emploi disponibles en France puis présente aux professionnels du champ addictologique comment structurer un programme naloxone. Pour illustrer ces propos, les actions du programme POP « Prévention et réduction des risques des surdoses liées aux Opioïdes en région PACA » seront détaillées. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | décès |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | naloxone |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | opioïdes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prévention |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | surdose |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | death |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | naloxone |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | opioids |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | overdose |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prevention |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chappuy, Mathieu |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Psychotropes | 31 | 2-3 | 2025-06-24 | p. 145-167 | 1245-2092 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-psychotropes-2025-2-3-page-145?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-psychotropes-2025-2-3-page-145?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux